CAMK2G and Erythema: Compared to IMQ‐treated WT mice, IMQ‐treated Camk2g–/– mice displayed significantly weakened psoriasis‐like manifestations, as indicated as reduced back skin thickness, mitigated erythema, and scaling (Figure 2a,b).